PetVivo Holdings, Inc. (PETV)
USD 0.63
(4.99%)
USD 0.63
(4.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.27 Million USD | 1082.93% |
| 2023 | -129.98 Thousand USD | 97.75% |
| 2022 | -5.77 Million USD | -914.43% |
| 2021 | 708.95 Thousand USD | 38.7% |
| 2020 | 511.13 Thousand USD | 420.91% |
| 2019 | 98.12 Thousand USD | 321.82% |
| 2018 | -44.23 Thousand USD | -110.85% |
| 2017 | 407.86 Thousand USD | 4.41% |
| 2016 | 390.65 Thousand USD | 161.53% |
| 2015 | 149.37 Thousand USD | -11.87% |
| 2014 | 169.48 Thousand USD | -2.88% |
| 2013 | 174.51 Thousand USD | 1081.14% |
| 2012 | 14.77 Thousand USD | 1488.63% |
| 2011 | -1064.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.28 Million USD | 9.45% |
| 2024 Q3 | 1.31 Million USD | 2.42% |
| 2024 Q4 | 1.27 Million USD | -3.1% |
| 2024 FY | 1.27 Million USD | 1082.93% |
| 2024 Q1 | 1.17 Million USD | 1004.96% |
| 2023 Q1 | -4.06 Million USD | 29.65% |
| 2023 Q2 | -2.03 Million USD | 49.86% |
| 2023 Q4 | -129.98 Thousand USD | -47.59% |
| 2023 FY | -129.98 Thousand USD | 97.75% |
| 2023 Q3 | -88.06 Thousand USD | 95.68% |
| 2022 Q4 | -5.77 Million USD | 21.73% |
| 2022 FY | -5.77 Million USD | -914.43% |
| 2022 Q2 | -8.63 Million USD | -2814.14% |
| 2022 Q1 | 317.96 Thousand USD | -55.15% |
| 2022 Q3 | -7.37 Million USD | 14.52% |
| 2021 Q2 | 777.96 Thousand USD | 70.07% |
| 2021 Q3 | 537.68 Thousand USD | -30.89% |
| 2021 FY | 708.95 Thousand USD | 38.7% |
| 2021 Q1 | 457.43 Thousand USD | -10.51% |
| 2021 Q4 | 708.95 Thousand USD | 31.85% |
| 2020 Q4 | 511.13 Thousand USD | 46.25% |
| 2020 Q1 | 399.8 Thousand USD | 307.45% |
| 2020 Q2 | 422.91 Thousand USD | 5.78% |
| 2020 Q3 | 349.49 Thousand USD | -17.36% |
| 2020 FY | 511.13 Thousand USD | 420.91% |
| 2019 Q4 | 98.12 Thousand USD | 397.66% |
| 2019 Q3 | -32.96 Thousand USD | -114.3% |
| 2019 Q2 | 230.52 Thousand USD | 227.22% |
| 2019 Q1 | 70.45 Thousand USD | 259.26% |
| 2019 FY | 98.12 Thousand USD | 321.82% |
| 2018 FY | -44.23 Thousand USD | -110.85% |
| 2018 Q4 | -44.23 Thousand USD | 75.27% |
| 2018 Q3 | -178.87 Thousand USD | -173.33% |
| 2018 Q2 | 243.92 Thousand USD | -43.46% |
| 2018 Q1 | 431.44 Thousand USD | 5.78% |
| 2017 FY | 407.86 Thousand USD | 4.41% |
| 2017 Q1 | 350.82 Thousand USD | -10.19% |
| 2017 Q2 | 340.31 Thousand USD | -3.0% |
| 2017 Q3 | 355.31 Thousand USD | 4.41% |
| 2017 Q4 | 407.86 Thousand USD | 14.79% |
| 2016 Q1 | 846.38 Thousand USD | 466.63% |
| 2016 Q3 | 1.3 Million USD | 21.8% |
| 2016 Q2 | 1.07 Million USD | 26.6% |
| 2016 Q4 | 390.65 Thousand USD | -70.07% |
| 2016 FY | 390.65 Thousand USD | 161.53% |
| 2015 Q2 | 116.04 Thousand USD | -40.81% |
| 2015 Q1 | 196.06 Thousand USD | 15.68% |
| 2015 FY | 149.37 Thousand USD | -11.87% |
| 2015 Q4 | 149.37 Thousand USD | -80.44% |
| 2015 Q3 | 763.64 Thousand USD | 558.07% |
| 2014 FY | 169.48 Thousand USD | -2.88% |
| 2014 Q3 | 149.23 Thousand USD | 0.27% |
| 2014 Q2 | 148.82 Thousand USD | -24.66% |
| 2014 Q1 | 197.54 Thousand USD | 13.2% |
| 2014 Q4 | 169.48 Thousand USD | 13.58% |
| 2013 FY | 174.51 Thousand USD | 1081.14% |
| 2013 Q1 | 14.61 Thousand USD | -1.08% |
| 2013 Q3 | -38.53 Thousand USD | -539.21% |
| 2013 Q4 | 174.51 Thousand USD | 552.86% |
| 2013 Q2 | 8774.00 USD | -39.97% |
| 2012 FY | 14.77 Thousand USD | 1488.63% |
| 2012 Q2 | -1129.00 USD | 0.0% |
| 2012 Q4 | 14.77 Thousand USD | 3002.75% |
| 2012 Q3 | -509.00 USD | 54.92% |
| 2011 Q4 | -1064.00 USD | 0.0% |
| 2011 FY | -1064.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acutus Medical, Inc. | 12.27 Million USD | 89.595% |
| Biotricity, Inc. | 23.09 Million USD | 94.467% |
| Cell MedX Corp. | 244.05 Thousand USD | -423.512% |
| Dynatronics Corporation | 6.2 Million USD | 79.406% |
| Nemaura Medical Inc. | 9.92 Million USD | 87.127% |
| RetinalGenix Technologies Inc. | 506.53 Thousand USD | -152.231% |
| Sonendo, Inc. | 26.34 Million USD | 95.15% |
| Telesis Bio, Inc. | 32.63 Million USD | 96.085% |
| Talis Biomedical Corporation | -57.06 Million USD | 102.239% |
| Viveve Medical, Inc. | -13.81 Million USD | 109.25% |